Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Medulloblastoma 2 Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Intracranial Germ Cell Tumors 1 Infratentorial Neoplasms 1 Glioma 1 Ependymoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 12 Etoposide 11 Granulocyte Colony-Stimulating Factor 7 Filgrastim 7 Carboplatin 7 etoposide phosphate 6 Vincristine 5 Methotrexate 5 Cisplatin 5 fludarabine 4 Topotecan 4 Thiotepa 4 Stem Cell Transplantation 4 Radiotherapy 4 Mesna 4 Melphalan 4 Temozolomide 3 Sirolimus 3 Ifosfamide 3 Busulfan 3 Automobiles 3 selinexor 2 sargramostim 2 fludarabine phosphate 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Leucovorin 2 Ipilimumab 2 Hydrocortisone 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rhabdoid Tumor × Craniospinal Irradiation × Clear all

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡